Volume 6, Issue 1 (3-2016)                   Iran J Ped Hematol Oncol 2016, 6(1): 32-37 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fallah R, Zare Bidoki S, Ordooei M. Evaluation Efficacy of Ferrous Sulfate Therapy on Headaches of 5-15 Years Old Iron Deficient Children with Migraine. Iran J Ped Hematol Oncol 2016; 6 (1) :32-37
URL: http://ijpho.ssu.ac.ir/article-1-240-en.html
Abstract:   (3063 Views)

Abstract
Background
Some researches have shown the association between iron deficiency and migraine headache in adults. The aim of present study was to evaluate efficacy of ferrous sulfate treatment on migraine headaches of 5-15 years old migraineur children with iron deficiency.
Materials and Methods
In a quasi- experimental study, monthly frequency, severity, duration and disability of headaches of 5-15 years old migraineur
children that prophylactic therapy was indicated in them and had iron deficiency who were referred to Pediatric  eurology Clinic of Shahid Sadoughi University of Medical Sciences, Yazd, Iran between 2013 and 2015 and were treated with 2mg/kg/day topiramate plus 4mg/kg/day of ferrous sulfate for three consecutive months, were evaluated and headache characteristics before and after treatment were compared.
Results
In this study, 98 children with mean age of 9.72±3.19 were evaluated that 31children (31.6%) had iron deficiency. Monthly
frequency (22.89±7.18 vs.14.5±4.56, P= 0.02), severity score (8.12± 1.76 vs. 5.03±1.15, P= 0.02) and disability score of
headache (38.23±10.7vs. 30.12±7.46, P= 0.03) were more in children with iron deficiency. Iron therapy was effective in
decreasing of monthlyfrequency 22.89± 7.18 vs. 10.13±4.51, P = 0.001), severity score (8.12±1.76 vs. 5.11±1.62, P =0.001),
duration (2.14±1.23 vs.1.14±1.01, P= 0.001) and disability score of headache (38.23±10.7 vs. 22.87±8.65, P= 0.01). 

Conclusion
In children, iron deficiency increased monthly frequency, severity and disability of migraine headache and ferrous sulfate
can be used as a safe and effective drug in migraine prophylaxis.

Full-Text [PDF 116 kb]   (1161 Downloads)    
Type of Study: Research | Subject: Heart
Received: 2016/02/24 | Accepted: 2016/02/24 | Published: 2016/02/24

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Pediatric Hematology and Oncology

Designed & Developed by : Yektaweb